Some investors asked questions on the investor interaction platform: Hello. Does the company produce“ β- Nicotinamide mononucleotide (NMN) or the raw material from which users make it? If so, what is the proportion. thank.
Sirio Pharma Co.Ltd(300791) (300791. SZ) said on the investor interaction platform on January 21 that the company has no production at present“ β- Nicotinamide mononucleotide (NMN) related products. As a b-end company of nutrition and health food, the company will develop and produce products with scientific basis for customers according to market expectations and customer needs.
